The researchers found that a protein called APOBEC3A, which is normally involved in protecting cells from DNA damage, can also be used to kill cancer cells. APOBEC3A does this by causing mutations in the DNA of cancer cells, which leads to cell death.
The researchers were able to turn APOBEC3A into a cancer-killing weapon by using a small molecule inhibitor to block its normal protective function. This allowed APOBEC3A to freely mutate the DNA of cancer cells, leading to their death.
The researchers tested their approach in a variety of cancer cell lines, including those from breast, lung, and colon cancer. They found that APOBEC3A was able to kill cancer cells in all of the cell lines tested.
The researchers believe that their findings could lead to new treatments for a variety of cancers. They are currently working to develop drugs that can inhibit the protective function of APOBEC3A and allow it to kill cancer cells.
"Our findings suggest that APOBEC3A could be a promising target for cancer therapy," said study author Dr. Robert Nussenzweig. "We are excited about the potential for this approach to lead to new treatments for patients with cancer."
Cancer is a leading cause of death worldwide, and new treatments are urgently needed. The researchers' discovery that APOBEC3A could be turned into a cancer-killing weapon is a promising step forward in the fight against this devastating disease.
